nodes	percent_of_prediction	percent_of_DWPC	metapath
Isradipine—CACNA1H—myometrium—uterine cancer	0.0101	0.0886	CbGeAlD
Isradipine—CACNA1C—myometrium—uterine cancer	0.00769	0.0675	CbGeAlD
Isradipine—CACNA1H—smooth muscle tissue—uterine cancer	0.00763	0.067	CbGeAlD
Isradipine—CACNA2D2—vagina—uterine cancer	0.00656	0.0576	CbGeAlD
Isradipine—CACNA1H—uterus—uterine cancer	0.00655	0.0574	CbGeAlD
Isradipine—CACNA1D—uterine cervix—uterine cancer	0.00648	0.0569	CbGeAlD
Isradipine—CACNA1H—female reproductive system—uterine cancer	0.00589	0.0516	CbGeAlD
Isradipine—CACNA1C—smooth muscle tissue—uterine cancer	0.00582	0.051	CbGeAlD
Isradipine—CACNA1C—decidua—uterine cancer	0.0057	0.05	CbGeAlD
Isradipine—CACNA1H—female gonad—uterine cancer	0.00536	0.047	CbGeAlD
Isradipine—CACNB2—vagina—uterine cancer	0.00503	0.0441	CbGeAlD
Isradipine—CACNA2D1—female gonad—uterine cancer	0.00475	0.0417	CbGeAlD
Isradipine—CACNA2D1—vagina—uterine cancer	0.00472	0.0414	CbGeAlD
Isradipine—CACNA1C—female reproductive system—uterine cancer	0.00448	0.0393	CbGeAlD
Isradipine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00439	0.463	CbGbCtD
Isradipine—CACNA2D2—lymph node—uterine cancer	0.00425	0.0372	CbGeAlD
Isradipine—CACNA1C—vagina—uterine cancer	0.00406	0.0356	CbGeAlD
Isradipine—CACNA1H—lymph node—uterine cancer	0.00344	0.0302	CbGeAlD
Isradipine—CACNB2—lymph node—uterine cancer	0.00325	0.0285	CbGeAlD
Isradipine—CACNA2D1—lymph node—uterine cancer	0.00305	0.0268	CbGeAlD
Isradipine—CYP3A4—Progesterone—uterine cancer	0.00291	0.307	CbGbCtD
Isradipine—CACNA1D—lymph node—uterine cancer	0.00284	0.0249	CbGeAlD
Isradipine—CACNA1H—Corticotropin-releasing hormone—STAR—uterine cancer	0.00265	0.0412	CbGpPWpGaD
Isradipine—CACNA1C—lymph node—uterine cancer	0.00262	0.023	CbGeAlD
Isradipine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00216	0.00266	CcSEcCtD
Isradipine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00214	0.00264	CcSEcCtD
Isradipine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00213	0.00262	CcSEcCtD
Isradipine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00212	0.00261	CcSEcCtD
Isradipine—Ill-defined disorder—Dactinomycin—uterine cancer	0.00212	0.00261	CcSEcCtD
Isradipine—Nocturia—Doxorubicin—uterine cancer	0.00211	0.0026	CcSEcCtD
Isradipine—Anaemia—Dactinomycin—uterine cancer	0.00211	0.0026	CcSEcCtD
Isradipine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.0021	0.00259	CcSEcCtD
Isradipine—Urticaria—Progesterone—uterine cancer	0.00209	0.00258	CcSEcCtD
Isradipine—Acute coronary syndrome—Etoposide—uterine cancer	0.00208	0.00256	CcSEcCtD
Isradipine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00207	0.00255	CcSEcCtD
Isradipine—Myocardial infarction—Etoposide—uterine cancer	0.00207	0.00255	CcSEcCtD
Isradipine—CYP3A4—renal system—uterine cancer	0.00207	0.0181	CbGeAlD
Isradipine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00206	0.00254	CcSEcCtD
Isradipine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00206	0.00253	CcSEcCtD
Isradipine—Malaise—Dactinomycin—uterine cancer	0.00206	0.00253	CcSEcCtD
Isradipine—Leukopenia—Dactinomycin—uterine cancer	0.00204	0.00251	CcSEcCtD
Isradipine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00204	0.00251	CcSEcCtD
Isradipine—Fluid retention—Epirubicin—uterine cancer	0.00201	0.00247	CcSEcCtD
Isradipine—Hepatobiliary disease—Etoposide—uterine cancer	0.002	0.00246	CcSEcCtD
Isradipine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00197	0.00242	CcSEcCtD
Isradipine—CACNA1S—Alzheimers Disease—MME—uterine cancer	0.00195	0.0302	CbGpPWpGaD
Isradipine—Discomfort—Dactinomycin—uterine cancer	0.00192	0.00236	CcSEcCtD
Isradipine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.0019	0.00233	CcSEcCtD
Isradipine—Asthenia—Progesterone—uterine cancer	0.00189	0.00233	CcSEcCtD
Isradipine—Hypoaesthesia—Etoposide—uterine cancer	0.00189	0.00232	CcSEcCtD
Isradipine—Urinary tract disorder—Etoposide—uterine cancer	0.00187	0.00231	CcSEcCtD
Isradipine—Pruritus—Progesterone—uterine cancer	0.00186	0.00229	CcSEcCtD
Isradipine—Oedema—Dactinomycin—uterine cancer	0.00186	0.00229	CcSEcCtD
Isradipine—Fluid retention—Doxorubicin—uterine cancer	0.00186	0.00229	CcSEcCtD
Isradipine—Urethral disorder—Etoposide—uterine cancer	0.00186	0.00229	CcSEcCtD
Isradipine—Thrombocytopenia—Dactinomycin—uterine cancer	0.00182	0.00224	CcSEcCtD
Isradipine—Diarrhoea—Progesterone—uterine cancer	0.0018	0.00222	CcSEcCtD
Isradipine—Eye disorder—Etoposide—uterine cancer	0.00177	0.00218	CcSEcCtD
Isradipine—Flushing—Etoposide—uterine cancer	0.00176	0.00217	CcSEcCtD
Isradipine—Cardiac disorder—Etoposide—uterine cancer	0.00176	0.00217	CcSEcCtD
Isradipine—Dizziness—Progesterone—uterine cancer	0.00174	0.00214	CcSEcCtD
Isradipine—Angiopathy—Etoposide—uterine cancer	0.00172	0.00212	CcSEcCtD
Isradipine—Immune system disorder—Etoposide—uterine cancer	0.00171	0.00211	CcSEcCtD
Isradipine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.00211	CcSEcCtD
Isradipine—Mediastinal disorder—Etoposide—uterine cancer	0.00171	0.0021	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.0017	0.00209	CcSEcCtD
Isradipine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00169	0.00208	CcSEcCtD
Isradipine—Vomiting—Progesterone—uterine cancer	0.00167	0.00206	CcSEcCtD
Isradipine—Rash—Progesterone—uterine cancer	0.00166	0.00204	CcSEcCtD
Isradipine—Dermatitis—Progesterone—uterine cancer	0.00166	0.00204	CcSEcCtD
Isradipine—CYP3A4—female reproductive system—uterine cancer	0.00166	0.0145	CbGeAlD
Isradipine—Headache—Progesterone—uterine cancer	0.00165	0.00203	CcSEcCtD
Isradipine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00163	0.00201	CcSEcCtD
Isradipine—Decreased appetite—Dactinomycin—uterine cancer	0.00162	0.00199	CcSEcCtD
Isradipine—Fatigue—Dactinomycin—uterine cancer	0.0016	0.00198	CcSEcCtD
Isradipine—Back pain—Etoposide—uterine cancer	0.0016	0.00197	CcSEcCtD
Isradipine—Muscle spasms—Etoposide—uterine cancer	0.00159	0.00195	CcSEcCtD
Isradipine—CACNA1H—Corticotropin-releasing hormone—CYP11A1—uterine cancer	0.00159	0.0246	CbGpPWpGaD
Isradipine—CACNA1D—Alzheimers Disease—MME—uterine cancer	0.00158	0.0246	CbGpPWpGaD
Isradipine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00158	0.00194	CcSEcCtD
Isradipine—Cardiac failure—Epirubicin—uterine cancer	0.00157	0.00194	CcSEcCtD
Isradipine—Cerebrovascular accident—Epirubicin—uterine cancer	0.00157	0.00193	CcSEcCtD
Isradipine—Lethargy—Epirubicin—uterine cancer	0.00157	0.00193	CcSEcCtD
Isradipine—Nausea—Progesterone—uterine cancer	0.00156	0.00193	CcSEcCtD
Isradipine—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.00156	0.0242	CbGpPWpGaD
Isradipine—Pain in extremity—Epirubicin—uterine cancer	0.00154	0.00189	CcSEcCtD
Isradipine—Feeling abnormal—Dactinomycin—uterine cancer	0.00153	0.00189	CcSEcCtD
Isradipine—Ill-defined disorder—Etoposide—uterine cancer	0.00153	0.00189	CcSEcCtD
Isradipine—Anaemia—Etoposide—uterine cancer	0.00153	0.00188	CcSEcCtD
Isradipine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00187	CcSEcCtD
Isradipine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.00185	CcSEcCtD
Isradipine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.00185	CcSEcCtD
Isradipine—CACNA1H—Axon guidance—PLXNA3—uterine cancer	0.0015	0.0233	CbGpPWpGaD
Isradipine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.00184	CcSEcCtD
Isradipine—Malaise—Etoposide—uterine cancer	0.00149	0.00183	CcSEcCtD
Isradipine—Leukopenia—Etoposide—uterine cancer	0.00148	0.00182	CcSEcCtD
Isradipine—Cardiac failure—Doxorubicin—uterine cancer	0.00146	0.00179	CcSEcCtD
Isradipine—Loss of consciousness—Etoposide—uterine cancer	0.00145	0.00179	CcSEcCtD
Isradipine—Cerebrovascular accident—Doxorubicin—uterine cancer	0.00145	0.00179	CcSEcCtD
Isradipine—Lethargy—Doxorubicin—uterine cancer	0.00145	0.00179	CcSEcCtD
Isradipine—Cough—Etoposide—uterine cancer	0.00144	0.00177	CcSEcCtD
Isradipine—Pain in extremity—Doxorubicin—uterine cancer	0.00142	0.00175	CcSEcCtD
Isradipine—Liver function test abnormal—Epirubicin—uterine cancer	0.00142	0.00175	CcSEcCtD
Isradipine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00175	CcSEcCtD
Isradipine—Chest pain—Etoposide—uterine cancer	0.00141	0.00173	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.0014	0.00172	CcSEcCtD
Isradipine—CACNA1C—Alzheimers Disease—MME—uterine cancer	0.00139	0.0216	CbGpPWpGaD
Isradipine—Discomfort—Etoposide—uterine cancer	0.00139	0.00171	CcSEcCtD
Isradipine—Breast disorder—Epirubicin—uterine cancer	0.00139	0.00171	CcSEcCtD
Isradipine—Anaphylactic shock—Etoposide—uterine cancer	0.00135	0.00166	CcSEcCtD
Isradipine—Asthenia—Dactinomycin—uterine cancer	0.00134	0.00164	CcSEcCtD
Isradipine—Thrombocytopenia—Etoposide—uterine cancer	0.00132	0.00162	CcSEcCtD
Isradipine—Tachycardia—Etoposide—uterine cancer	0.00131	0.00162	CcSEcCtD
Isradipine—Liver function test abnormal—Doxorubicin—uterine cancer	0.00131	0.00162	CcSEcCtD
Isradipine—Skin disorder—Etoposide—uterine cancer	0.00131	0.00161	CcSEcCtD
Isradipine—Hyperhidrosis—Etoposide—uterine cancer	0.0013	0.0016	CcSEcCtD
Isradipine—CYP3A4—Etoposide—uterine cancer	0.0013	0.137	CbGbCtD
Isradipine—Angina pectoris—Epirubicin—uterine cancer	0.00129	0.00159	CcSEcCtD
Isradipine—Breast disorder—Doxorubicin—uterine cancer	0.00128	0.00158	CcSEcCtD
Isradipine—CACNA1S—Axon guidance—PLXNA3—uterine cancer	0.00128	0.0198	CbGpPWpGaD
Isradipine—Diarrhoea—Dactinomycin—uterine cancer	0.00127	0.00157	CcSEcCtD
Isradipine—Hypotension—Etoposide—uterine cancer	0.00126	0.00155	CcSEcCtD
Isradipine—Pollakiuria—Epirubicin—uterine cancer	0.00123	0.00151	CcSEcCtD
Isradipine—Photosensitivity reaction—Epirubicin—uterine cancer	0.00121	0.00149	CcSEcCtD
Isradipine—Paraesthesia—Etoposide—uterine cancer	0.00121	0.00149	CcSEcCtD
Isradipine—Weight increased—Epirubicin—uterine cancer	0.00121	0.00149	CcSEcCtD
Isradipine—Dyspnoea—Etoposide—uterine cancer	0.0012	0.00148	CcSEcCtD
Isradipine—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.0012	0.0186	CbGpPWpGaD
Isradipine—Somnolence—Etoposide—uterine cancer	0.0012	0.00147	CcSEcCtD
Isradipine—Angina pectoris—Doxorubicin—uterine cancer	0.0012	0.00147	CcSEcCtD
Isradipine—Drowsiness—Epirubicin—uterine cancer	0.00118	0.00146	CcSEcCtD
Isradipine—Vomiting—Dactinomycin—uterine cancer	0.00118	0.00146	CcSEcCtD
Isradipine—Rash—Dactinomycin—uterine cancer	0.00117	0.00145	CcSEcCtD
Isradipine—Decreased appetite—Etoposide—uterine cancer	0.00117	0.00144	CcSEcCtD
Isradipine—Gastrointestinal disorder—Etoposide—uterine cancer	0.00116	0.00143	CcSEcCtD
Isradipine—Fatigue—Etoposide—uterine cancer	0.00116	0.00143	CcSEcCtD
Isradipine—CACNA2D2—Neuronal System—ABCC9—uterine cancer	0.00116	0.018	CbGpPWpGaD
Isradipine—Constipation—Etoposide—uterine cancer	0.00115	0.00142	CcSEcCtD
Isradipine—Pollakiuria—Doxorubicin—uterine cancer	0.00114	0.0014	CcSEcCtD
Isradipine—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—uterine cancer	0.00113	0.0176	CbGpPWpGaD
Isradipine—CACNA2D2—Integration of energy metabolism—STK11—uterine cancer	0.00112	0.0174	CbGpPWpGaD
Isradipine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00112	0.00138	CcSEcCtD
Isradipine—Hepatobiliary disease—Epirubicin—uterine cancer	0.00112	0.00138	CcSEcCtD
Isradipine—Weight increased—Doxorubicin—uterine cancer	0.00112	0.00138	CcSEcCtD
Isradipine—Feeling abnormal—Etoposide—uterine cancer	0.00111	0.00137	CcSEcCtD
Isradipine—Nausea—Dactinomycin—uterine cancer	0.00111	0.00136	CcSEcCtD
Isradipine—Drowsiness—Doxorubicin—uterine cancer	0.0011	0.00135	CcSEcCtD
Isradipine—CACNB2—Axon guidance—PLXNA3—uterine cancer	0.00109	0.017	CbGpPWpGaD
Isradipine—Bradycardia—Epirubicin—uterine cancer	0.00108	0.00133	CcSEcCtD
Isradipine—CACNA1H—Developmental Biology—PLXNA3—uterine cancer	0.00107	0.0166	CbGpPWpGaD
Isradipine—Urticaria—Etoposide—uterine cancer	0.00107	0.00132	CcSEcCtD
Isradipine—Hepatitis—Epirubicin—uterine cancer	0.00106	0.00131	CcSEcCtD
Isradipine—Hypoaesthesia—Epirubicin—uterine cancer	0.00106	0.0013	CcSEcCtD
Isradipine—Urinary tract disorder—Epirubicin—uterine cancer	0.00105	0.00129	CcSEcCtD
Isradipine—Oedema peripheral—Epirubicin—uterine cancer	0.00105	0.00129	CcSEcCtD
Isradipine—Connective tissue disorder—Epirubicin—uterine cancer	0.00104	0.00129	CcSEcCtD
Isradipine—Urethral disorder—Epirubicin—uterine cancer	0.00104	0.00128	CcSEcCtD
Isradipine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.00104	0.00128	CcSEcCtD
Isradipine—CACNA1D—Axon guidance—PLXNA3—uterine cancer	0.00104	0.0161	CbGpPWpGaD
Isradipine—Visual impairment—Epirubicin—uterine cancer	0.00102	0.00126	CcSEcCtD
Isradipine—Bradycardia—Doxorubicin—uterine cancer	0.001	0.00123	CcSEcCtD
Isradipine—Eye disorder—Epirubicin—uterine cancer	0.000993	0.00122	CcSEcCtD
Isradipine—Flushing—Epirubicin—uterine cancer	0.000986	0.00121	CcSEcCtD
Isradipine—Cardiac disorder—Epirubicin—uterine cancer	0.000986	0.00121	CcSEcCtD
Isradipine—Hepatitis—Doxorubicin—uterine cancer	0.000983	0.00121	CcSEcCtD
Isradipine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000979	0.0012	CcSEcCtD
Isradipine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000971	0.0012	CcSEcCtD
Isradipine—Oedema peripheral—Doxorubicin—uterine cancer	0.000969	0.00119	CcSEcCtD
Isradipine—Asthenia—Etoposide—uterine cancer	0.000967	0.00119	CcSEcCtD
Isradipine—Connective tissue disorder—Doxorubicin—uterine cancer	0.000966	0.00119	CcSEcCtD
Isradipine—Angiopathy—Epirubicin—uterine cancer	0.000964	0.00119	CcSEcCtD
Isradipine—Urethral disorder—Doxorubicin—uterine cancer	0.000964	0.00119	CcSEcCtD
Isradipine—Immune system disorder—Epirubicin—uterine cancer	0.00096	0.00118	CcSEcCtD
Isradipine—Mediastinal disorder—Epirubicin—uterine cancer	0.000958	0.00118	CcSEcCtD
Isradipine—Pruritus—Etoposide—uterine cancer	0.000953	0.00117	CcSEcCtD
Isradipine—Visual impairment—Doxorubicin—uterine cancer	0.000948	0.00117	CcSEcCtD
Isradipine—Mental disorder—Epirubicin—uterine cancer	0.000931	0.00115	CcSEcCtD
Isradipine—Malnutrition—Epirubicin—uterine cancer	0.000925	0.00114	CcSEcCtD
Isradipine—Diarrhoea—Etoposide—uterine cancer	0.000922	0.00113	CcSEcCtD
Isradipine—Eye disorder—Doxorubicin—uterine cancer	0.000919	0.00113	CcSEcCtD
Isradipine—Flushing—Doxorubicin—uterine cancer	0.000913	0.00112	CcSEcCtD
Isradipine—Cardiac disorder—Doxorubicin—uterine cancer	0.000913	0.00112	CcSEcCtD
Isradipine—CACNA1S—Developmental Biology—PLXNA3—uterine cancer	0.00091	0.0141	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—PLXNA3—uterine cancer	0.00091	0.0141	CbGpPWpGaD
Isradipine—Tension—Epirubicin—uterine cancer	0.000908	0.00112	CcSEcCtD
Isradipine—Nervousness—Epirubicin—uterine cancer	0.000899	0.00111	CcSEcCtD
Isradipine—Back pain—Epirubicin—uterine cancer	0.000895	0.0011	CcSEcCtD
Isradipine—Angiopathy—Doxorubicin—uterine cancer	0.000892	0.0011	CcSEcCtD
Isradipine—Dizziness—Etoposide—uterine cancer	0.000891	0.0011	CcSEcCtD
Isradipine—Muscle spasms—Epirubicin—uterine cancer	0.00089	0.0011	CcSEcCtD
Isradipine—Immune system disorder—Doxorubicin—uterine cancer	0.000888	0.00109	CcSEcCtD
Isradipine—CYP3A4—Doxorubicin—uterine cancer	0.000888	0.0936	CbGbCtD
Isradipine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000886	0.00109	CcSEcCtD
Isradipine—Vision blurred—Epirubicin—uterine cancer	0.000872	0.00107	CcSEcCtD
Isradipine—Mental disorder—Doxorubicin—uterine cancer	0.000862	0.00106	CcSEcCtD
Isradipine—Ill-defined disorder—Epirubicin—uterine cancer	0.000858	0.00106	CcSEcCtD
Isradipine—Vomiting—Etoposide—uterine cancer	0.000857	0.00105	CcSEcCtD
Isradipine—Malnutrition—Doxorubicin—uterine cancer	0.000856	0.00105	CcSEcCtD
Isradipine—Anaemia—Epirubicin—uterine cancer	0.000855	0.00105	CcSEcCtD
Isradipine—Rash—Etoposide—uterine cancer	0.000849	0.00105	CcSEcCtD
Isradipine—Dermatitis—Etoposide—uterine cancer	0.000849	0.00104	CcSEcCtD
Isradipine—Headache—Etoposide—uterine cancer	0.000844	0.00104	CcSEcCtD
Isradipine—Tension—Doxorubicin—uterine cancer	0.00084	0.00103	CcSEcCtD
Isradipine—Malaise—Epirubicin—uterine cancer	0.000834	0.00103	CcSEcCtD
Isradipine—Nervousness—Doxorubicin—uterine cancer	0.000832	0.00102	CcSEcCtD
Isradipine—Syncope—Epirubicin—uterine cancer	0.00083	0.00102	CcSEcCtD
Isradipine—Leukopenia—Epirubicin—uterine cancer	0.000828	0.00102	CcSEcCtD
Isradipine—Back pain—Doxorubicin—uterine cancer	0.000828	0.00102	CcSEcCtD
Isradipine—Muscle spasms—Doxorubicin—uterine cancer	0.000823	0.00101	CcSEcCtD
Isradipine—Palpitations—Epirubicin—uterine cancer	0.000818	0.00101	CcSEcCtD
Isradipine—Loss of consciousness—Epirubicin—uterine cancer	0.000813	0.001	CcSEcCtD
Isradipine—Cough—Epirubicin—uterine cancer	0.000807	0.000994	CcSEcCtD
Isradipine—Vision blurred—Doxorubicin—uterine cancer	0.000807	0.000994	CcSEcCtD
Isradipine—CACNA1S—Calcium Regulation in the Cardiac Cell—YWHAE—uterine cancer	0.000804	0.0125	CbGpPWpGaD
Isradipine—Nausea—Etoposide—uterine cancer	0.0008	0.000985	CcSEcCtD
Isradipine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000794	0.000978	CcSEcCtD
Isradipine—CACNB2—Neuronal System—ABCC9—uterine cancer	0.000794	0.0123	CbGpPWpGaD
Isradipine—Anaemia—Doxorubicin—uterine cancer	0.000791	0.000974	CcSEcCtD
Isradipine—Arthralgia—Epirubicin—uterine cancer	0.000788	0.00097	CcSEcCtD
Isradipine—Chest pain—Epirubicin—uterine cancer	0.000788	0.00097	CcSEcCtD
Isradipine—Anxiety—Epirubicin—uterine cancer	0.000785	0.000967	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000782	0.000963	CcSEcCtD
Isradipine—CACNB2—Developmental Biology—PLXNA3—uterine cancer	0.00078	0.0121	CbGpPWpGaD
Isradipine—Discomfort—Epirubicin—uterine cancer	0.000778	0.000958	CcSEcCtD
Isradipine—Malaise—Doxorubicin—uterine cancer	0.000772	0.000951	CcSEcCtD
Isradipine—Dry mouth—Epirubicin—uterine cancer	0.00077	0.000949	CcSEcCtD
Isradipine—CACNB2—Integration of energy metabolism—STK11—uterine cancer	0.00077	0.0119	CbGpPWpGaD
Isradipine—Syncope—Doxorubicin—uterine cancer	0.000768	0.000945	CcSEcCtD
Isradipine—Leukopenia—Doxorubicin—uterine cancer	0.000766	0.000944	CcSEcCtD
Isradipine—Palpitations—Doxorubicin—uterine cancer	0.000757	0.000932	CcSEcCtD
Isradipine—Anaphylactic shock—Epirubicin—uterine cancer	0.000755	0.00093	CcSEcCtD
Isradipine—Oedema—Epirubicin—uterine cancer	0.000755	0.00093	CcSEcCtD
Isradipine—Loss of consciousness—Doxorubicin—uterine cancer	0.000752	0.000927	CcSEcCtD
Isradipine—Cough—Doxorubicin—uterine cancer	0.000747	0.00092	CcSEcCtD
Isradipine—Shock—Epirubicin—uterine cancer	0.000743	0.000915	CcSEcCtD
Isradipine—Nervous system disorder—Epirubicin—uterine cancer	0.000741	0.000912	CcSEcCtD
Isradipine—Thrombocytopenia—Epirubicin—uterine cancer	0.000739	0.00091	CcSEcCtD
Isradipine—CACNA1D—Developmental Biology—PLXNA3—uterine cancer	0.000739	0.0115	CbGpPWpGaD
Isradipine—Tachycardia—Epirubicin—uterine cancer	0.000737	0.000908	CcSEcCtD
Isradipine—Skin disorder—Epirubicin—uterine cancer	0.000733	0.000903	CcSEcCtD
Isradipine—Hyperhidrosis—Epirubicin—uterine cancer	0.00073	0.000899	CcSEcCtD
Isradipine—CACNA1D—Integration of energy metabolism—STK11—uterine cancer	0.000729	0.0113	CbGpPWpGaD
Isradipine—Chest pain—Doxorubicin—uterine cancer	0.000729	0.000898	CcSEcCtD
Isradipine—Arthralgia—Doxorubicin—uterine cancer	0.000729	0.000898	CcSEcCtD
Isradipine—Anxiety—Doxorubicin—uterine cancer	0.000726	0.000894	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000724	0.000891	CcSEcCtD
Isradipine—Discomfort—Doxorubicin—uterine cancer	0.00072	0.000887	CcSEcCtD
Isradipine—Dry mouth—Doxorubicin—uterine cancer	0.000713	0.000878	CcSEcCtD
Isradipine—Hypotension—Epirubicin—uterine cancer	0.000706	0.000869	CcSEcCtD
Isradipine—Oedema—Doxorubicin—uterine cancer	0.000699	0.00086	CcSEcCtD
Isradipine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000699	0.00086	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000688	0.000847	CcSEcCtD
Isradipine—Shock—Doxorubicin—uterine cancer	0.000687	0.000846	CcSEcCtD
Isradipine—Nervous system disorder—Doxorubicin—uterine cancer	0.000685	0.000844	CcSEcCtD
Isradipine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000684	0.000842	CcSEcCtD
Isradipine—Insomnia—Epirubicin—uterine cancer	0.000683	0.000841	CcSEcCtD
Isradipine—Tachycardia—Doxorubicin—uterine cancer	0.000682	0.00084	CcSEcCtD
Isradipine—Skin disorder—Doxorubicin—uterine cancer	0.000679	0.000836	CcSEcCtD
Isradipine—Paraesthesia—Epirubicin—uterine cancer	0.000678	0.000835	CcSEcCtD
Isradipine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000675	0.000832	CcSEcCtD
Isradipine—Dyspnoea—Epirubicin—uterine cancer	0.000673	0.000829	CcSEcCtD
Isradipine—Somnolence—Epirubicin—uterine cancer	0.000671	0.000827	CcSEcCtD
Isradipine—Dyspepsia—Epirubicin—uterine cancer	0.000665	0.000819	CcSEcCtD
Isradipine—Decreased appetite—Epirubicin—uterine cancer	0.000656	0.000808	CcSEcCtD
Isradipine—Hypotension—Doxorubicin—uterine cancer	0.000653	0.000804	CcSEcCtD
Isradipine—CACNA1D—Calcium Regulation in the Cardiac Cell—YWHAE—uterine cancer	0.000653	0.0101	CbGpPWpGaD
Isradipine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000652	0.000803	CcSEcCtD
Isradipine—Fatigue—Epirubicin—uterine cancer	0.000651	0.000802	CcSEcCtD
Isradipine—CACNA1C—Developmental Biology—PLXNA3—uterine cancer	0.000649	0.0101	CbGpPWpGaD
Isradipine—Constipation—Epirubicin—uterine cancer	0.000646	0.000795	CcSEcCtD
Isradipine—CACNA1C—Integration of energy metabolism—STK11—uterine cancer	0.000641	0.00994	CbGpPWpGaD
Isradipine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000637	0.000784	CcSEcCtD
Isradipine—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—uterine cancer	0.000633	0.00982	CbGpPWpGaD
Isradipine—Insomnia—Doxorubicin—uterine cancer	0.000632	0.000778	CcSEcCtD
Isradipine—Paraesthesia—Doxorubicin—uterine cancer	0.000627	0.000773	CcSEcCtD
Isradipine—Dyspnoea—Doxorubicin—uterine cancer	0.000623	0.000767	CcSEcCtD
Isradipine—Feeling abnormal—Epirubicin—uterine cancer	0.000622	0.000766	CcSEcCtD
Isradipine—Somnolence—Doxorubicin—uterine cancer	0.000621	0.000765	CcSEcCtD
Isradipine—Dyspepsia—Doxorubicin—uterine cancer	0.000615	0.000757	CcSEcCtD
Isradipine—Decreased appetite—Doxorubicin—uterine cancer	0.000607	0.000748	CcSEcCtD
Isradipine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000603	0.000743	CcSEcCtD
Isradipine—Fatigue—Doxorubicin—uterine cancer	0.000602	0.000742	CcSEcCtD
Isradipine—Urticaria—Epirubicin—uterine cancer	0.0006	0.000739	CcSEcCtD
Isradipine—Constipation—Doxorubicin—uterine cancer	0.000598	0.000736	CcSEcCtD
Isradipine—Feeling abnormal—Doxorubicin—uterine cancer	0.000576	0.000709	CcSEcCtD
Isradipine—CACNA1C—Calcium Regulation in the Cardiac Cell—YWHAE—uterine cancer	0.000573	0.0089	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—HNF1B—uterine cancer	0.000563	0.00875	CbGpPWpGaD
Isradipine—Urticaria—Doxorubicin—uterine cancer	0.000555	0.000684	CcSEcCtD
Isradipine—CACNA1H—NCAM signaling for neurite out-growth—NRAS—uterine cancer	0.000554	0.00861	CbGpPWpGaD
Isradipine—CACNA1H—Corticotropin-releasing hormone—CXCL8—uterine cancer	0.000543	0.00842	CbGpPWpGaD
Isradipine—Asthenia—Epirubicin—uterine cancer	0.000542	0.000667	CcSEcCtD
Isradipine—Pruritus—Epirubicin—uterine cancer	0.000534	0.000658	CcSEcCtD
Isradipine—Diarrhoea—Epirubicin—uterine cancer	0.000517	0.000636	CcSEcCtD
Isradipine—CACNA1S—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—uterine cancer	0.000506	0.00785	CbGpPWpGaD
Isradipine—Asthenia—Doxorubicin—uterine cancer	0.000501	0.000617	CcSEcCtD
Isradipine—CACNA1H—Corticotropin-releasing hormone—CTNNB1—uterine cancer	0.000501	0.00777	CbGpPWpGaD
Isradipine—Dizziness—Epirubicin—uterine cancer	0.000499	0.000615	CcSEcCtD
Isradipine—Pruritus—Doxorubicin—uterine cancer	0.000494	0.000609	CcSEcCtD
Isradipine—Vomiting—Epirubicin—uterine cancer	0.00048	0.000591	CcSEcCtD
Isradipine—CACNA1S—Developmental Biology—HNF1B—uterine cancer	0.000478	0.00742	CbGpPWpGaD
Isradipine—Diarrhoea—Doxorubicin—uterine cancer	0.000478	0.000589	CcSEcCtD
Isradipine—CACNA1H—NCAM signaling for neurite out-growth—KRAS—uterine cancer	0.000477	0.00741	CbGpPWpGaD
Isradipine—Rash—Epirubicin—uterine cancer	0.000476	0.000586	CcSEcCtD
Isradipine—Dermatitis—Epirubicin—uterine cancer	0.000476	0.000586	CcSEcCtD
Isradipine—Headache—Epirubicin—uterine cancer	0.000473	0.000583	CcSEcCtD
Isradipine—CACNA1S—NCAM signaling for neurite out-growth—NRAS—uterine cancer	0.00047	0.0073	CbGpPWpGaD
Isradipine—Dizziness—Doxorubicin—uterine cancer	0.000462	0.000569	CcSEcCtD
Isradipine—Nausea—Epirubicin—uterine cancer	0.000449	0.000552	CcSEcCtD
Isradipine—Vomiting—Doxorubicin—uterine cancer	0.000444	0.000547	CcSEcCtD
Isradipine—Rash—Doxorubicin—uterine cancer	0.000441	0.000542	CcSEcCtD
Isradipine—Dermatitis—Doxorubicin—uterine cancer	0.00044	0.000542	CcSEcCtD
Isradipine—Headache—Doxorubicin—uterine cancer	0.000438	0.000539	CcSEcCtD
Isradipine—CACNB2—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—uterine cancer	0.000434	0.00673	CbGpPWpGaD
Isradipine—Nausea—Doxorubicin—uterine cancer	0.000415	0.000511	CcSEcCtD
Isradipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—uterine cancer	0.000411	0.00637	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—HNF1B—uterine cancer	0.00041	0.00636	CbGpPWpGaD
Isradipine—CACNA1H—NCAM signaling for neurite out-growth—HRAS—uterine cancer	0.000406	0.0063	CbGpPWpGaD
Isradipine—CACNA1S—NCAM signaling for neurite out-growth—KRAS—uterine cancer	0.000405	0.00629	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—NDUFB11—uterine cancer	0.000404	0.00626	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—SRD5A2—uterine cancer	0.000404	0.00626	CbGpPWpGaD
Isradipine—CACNB2—NCAM signaling for neurite out-growth—NRAS—uterine cancer	0.000403	0.00626	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—HNF1B—uterine cancer	0.000388	0.00603	CbGpPWpGaD
Isradipine—CACNA1D—NCAM signaling for neurite out-growth—NRAS—uterine cancer	0.000382	0.00593	CbGpPWpGaD
Isradipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—uterine cancer	0.000361	0.0056	CbGpPWpGaD
Isradipine—CACNB2—NCAM signaling for neurite out-growth—KRAS—uterine cancer	0.000347	0.00539	CbGpPWpGaD
Isradipine—CACNA1S—NCAM signaling for neurite out-growth—HRAS—uterine cancer	0.000344	0.00534	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—HNF1B—uterine cancer	0.000341	0.00529	CbGpPWpGaD
Isradipine—CACNA1C—NCAM signaling for neurite out-growth—NRAS—uterine cancer	0.000336	0.00521	CbGpPWpGaD
Isradipine—CACNA1D—NCAM signaling for neurite out-growth—KRAS—uterine cancer	0.000329	0.0051	CbGpPWpGaD
Isradipine—CACNA1S—Alzheimers Disease—TP53—uterine cancer	0.000319	0.00496	CbGpPWpGaD
Isradipine—CACNB2—NCAM signaling for neurite out-growth—HRAS—uterine cancer	0.000295	0.00458	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—AKR1B1—uterine cancer	0.000292	0.00453	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—STAR—uterine cancer	0.000292	0.00453	CbGpPWpGaD
Isradipine—CACNA1C—NCAM signaling for neurite out-growth—KRAS—uterine cancer	0.000289	0.00448	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—MET—uterine cancer	0.000286	0.00444	CbGpPWpGaD
Isradipine—CACNA1H—Corticotropin-releasing hormone—AKT1—uterine cancer	0.000281	0.00437	CbGpPWpGaD
Isradipine—CACNA1D—NCAM signaling for neurite out-growth—HRAS—uterine cancer	0.000279	0.00434	CbGpPWpGaD
Isradipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000278	0.00432	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—NDUFB11—uterine cancer	0.000277	0.00429	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—SRD5A2—uterine cancer	0.000277	0.00429	CbGpPWpGaD
Isradipine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000275	0.00426	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—NDUFB11—uterine cancer	0.000262	0.00407	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—SRD5A2—uterine cancer	0.000262	0.00407	CbGpPWpGaD
Isradipine—CACNA1D—Alzheimers Disease—TP53—uterine cancer	0.000259	0.00402	CbGpPWpGaD
Isradipine—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000253	0.00393	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—SMAD3—uterine cancer	0.000249	0.00387	CbGpPWpGaD
Isradipine—CACNA1C—NCAM signaling for neurite out-growth—HRAS—uterine cancer	0.000246	0.00381	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—MET—uterine cancer	0.000243	0.00377	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—SRD5A2—uterine cancer	0.00023	0.00357	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—NDUFB11—uterine cancer	0.00023	0.00357	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—POLD1—uterine cancer	0.000229	0.00355	CbGpPWpGaD
Isradipine—CACNA1C—Alzheimers Disease—TP53—uterine cancer	0.000228	0.00353	CbGpPWpGaD
Isradipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000226	0.0035	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—AKR1C1—uterine cancer	0.000214	0.00332	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000212	0.0033	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—SMAD3—uterine cancer	0.000211	0.00328	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—ERBB2—uterine cancer	0.000209	0.00324	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—MET—uterine cancer	0.000208	0.00323	CbGpPWpGaD
Isradipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000205	0.00318	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—MET—uterine cancer	0.000204	0.00317	CbGpPWpGaD
Isradipine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000202	0.00314	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—AKR1B1—uterine cancer	0.0002	0.0031	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—STAR—uterine cancer	0.0002	0.0031	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	0.000197	0.00307	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—MET—uterine cancer	0.000197	0.00306	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—RRM2—uterine cancer	0.000191	0.00296	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—STAR—uterine cancer	0.000189	0.00294	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—AKR1B1—uterine cancer	0.000189	0.00294	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—DCN—uterine cancer	0.000185	0.00288	CbGpPWpGaD
Isradipine—CACNA2D2—Transmission across Chemical Synapses—HRAS—uterine cancer	0.000182	0.00282	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—SMAD3—uterine cancer	0.000181	0.00281	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—ERBB2—uterine cancer	0.000177	0.00275	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CYP11A1—uterine cancer	0.000175	0.00271	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—MET—uterine cancer	0.000173	0.00269	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—MET—uterine cancer	0.000173	0.00269	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—SMAD3—uterine cancer	0.000172	0.00266	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—STAR—uterine cancer	0.000166	0.00258	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—AKR1B1—uterine cancer	0.000166	0.00258	CbGpPWpGaD
Isradipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000166	0.00258	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—AKR1C3—uterine cancer	0.000165	0.00256	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—VEGFA—uterine cancer	0.000161	0.0025	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—NRAS—uterine cancer	0.000159	0.00247	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—POLD1—uterine cancer	0.000157	0.00244	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—ERBB2—uterine cancer	0.000152	0.00236	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—SMAD3—uterine cancer	0.000151	0.00234	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—ERBB2—uterine cancer	0.000149	0.00232	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—POLD1—uterine cancer	0.000149	0.00231	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MET—uterine cancer	0.000148	0.0023	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—AKR1C1—uterine cancer	0.000147	0.00228	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	0.000145	0.00225	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—ERBB2—uterine cancer	0.000144	0.00224	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MET—uterine cancer	0.000141	0.00218	CbGpPWpGaD
Isradipine—CACNA2D2—Neuronal System—HRAS—uterine cancer	0.000139	0.00216	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—AKR1C1—uterine cancer	0.000139	0.00216	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—KRAS—uterine cancer	0.000137	0.00212	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—VEGFA—uterine cancer	0.000137	0.00212	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—NRAS—uterine cancer	0.000135	0.00209	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—RRM2—uterine cancer	0.000131	0.00203	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—POLD1—uterine cancer	0.000131	0.00203	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—CTNNB1—uterine cancer	0.00013	0.00203	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—STK11—uterine cancer	0.000128	0.00199	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CYP19A1—uterine cancer	0.000128	0.00199	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	0.000127	0.00198	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—DCN—uterine cancer	0.000127	0.00197	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—ERBB2—uterine cancer	0.000127	0.00196	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—ERBB2—uterine cancer	0.000127	0.00196	CbGpPWpGaD
Isradipine—CACNB2—Transmission across Chemical Synapses—HRAS—uterine cancer	0.000124	0.00193	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—RRM2—uterine cancer	0.000124	0.00192	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MET—uterine cancer	0.000124	0.00192	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—AKR1C1—uterine cancer	0.000122	0.0019	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—EP300—uterine cancer	0.000121	0.00188	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—DCN—uterine cancer	0.00012	0.00187	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	0.00012	0.00186	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYP11A1—uterine cancer	0.00012	0.00186	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	0.000118	0.00183	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—VEGFA—uterine cancer	0.000117	0.00182	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—HRAS—uterine cancer	0.000116	0.00181	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—KRAS—uterine cancer	0.000116	0.0018	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—NRAS—uterine cancer	0.000116	0.0018	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—VEGFA—uterine cancer	0.000115	0.00178	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—NRAS—uterine cancer	0.000113	0.00176	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYP11A1—uterine cancer	0.000113	0.00176	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—AKR1C3—uterine cancer	0.000113	0.00175	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	0.000112	0.00173	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—VEGFA—uterine cancer	0.000111	0.00172	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—CTNNB1—uterine cancer	0.000111	0.00172	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—NRAS—uterine cancer	0.00011	0.0017	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—RRM2—uterine cancer	0.000109	0.00169	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—ERBB2—uterine cancer	0.000109	0.00168	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—AKR1C3—uterine cancer	0.000107	0.00166	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—DCN—uterine cancer	0.000106	0.00164	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—EP300—uterine cancer	0.000103	0.0016	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—ERBB2—uterine cancer	0.000103	0.00159	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—KRAS—uterine cancer	9.96e-05	0.00155	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP11A1—uterine cancer	9.96e-05	0.00155	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—HRAS—uterine cancer	9.87e-05	0.00153	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—KRAS—uterine cancer	9.77e-05	0.00152	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—VEGFA—uterine cancer	9.75e-05	0.00151	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—VEGFA—uterine cancer	9.75e-05	0.00151	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—MTHFR—uterine cancer	9.65e-05	0.0015	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—NRAS—uterine cancer	9.63e-05	0.00149	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—NRAS—uterine cancer	9.63e-05	0.00149	CbGpPWpGaD
Isradipine—CACNB2—Neuronal System—HRAS—uterine cancer	9.54e-05	0.00148	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—CTNNB1—uterine cancer	9.49e-05	0.00147	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—KRAS—uterine cancer	9.43e-05	0.00146	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—AKR1C3—uterine cancer	9.4e-05	0.00146	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—ERBB2—uterine cancer	9.03e-05	0.0014	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—CTNNB1—uterine cancer	8.99e-05	0.0014	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—EP300—uterine cancer	8.82e-05	0.00137	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	8.81e-05	0.00137	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—STK11—uterine cancer	8.8e-05	0.00137	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYP19A1—uterine cancer	8.8e-05	0.00137	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	8.69e-05	0.00135	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—HRAS—uterine cancer	8.46e-05	0.00131	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—VEGFA—uterine cancer	8.36e-05	0.0013	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—EP300—uterine cancer	8.36e-05	0.0013	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—STK11—uterine cancer	8.34e-05	0.00129	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYP19A1—uterine cancer	8.34e-05	0.00129	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—HRAS—uterine cancer	8.3e-05	0.00129	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—KRAS—uterine cancer	8.29e-05	0.00129	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—KRAS—uterine cancer	8.28e-05	0.00129	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—NRAS—uterine cancer	8.26e-05	0.00128	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—HRAS—uterine cancer	8.01e-05	0.00124	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—VEGFA—uterine cancer	7.91e-05	0.00123	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—CTNNB1—uterine cancer	7.9e-05	0.00123	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—NRAS—uterine cancer	7.82e-05	0.00121	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—EP300—uterine cancer	7.34e-05	0.00114	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—AKT1—uterine cancer	7.33e-05	0.00114	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—STK11—uterine cancer	7.33e-05	0.00114	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP19A1—uterine cancer	7.33e-05	0.00114	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—KRAS—uterine cancer	7.11e-05	0.0011	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—HRAS—uterine cancer	7.04e-05	0.00109	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—HRAS—uterine cancer	7.04e-05	0.00109	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—VEGFA—uterine cancer	6.95e-05	0.00108	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—NRAS—uterine cancer	6.87e-05	0.00107	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—KRAS—uterine cancer	6.73e-05	0.00104	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—MTHFR—uterine cancer	6.62e-05	0.00103	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—MTHFR—uterine cancer	6.26e-05	0.000972	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—AKT1—uterine cancer	6.22e-05	0.000965	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—HRAS—uterine cancer	6.04e-05	0.000937	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—KRAS—uterine cancer	5.91e-05	0.000918	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—HRAS—uterine cancer	5.72e-05	0.000888	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—MTHFR—uterine cancer	5.5e-05	0.000854	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PTEN—uterine cancer	5.37e-05	0.000833	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—AKT1—uterine cancer	5.33e-05	0.000828	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—EP300—uterine cancer	5.12e-05	0.000795	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—AKT1—uterine cancer	5.05e-05	0.000784	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—HRAS—uterine cancer	5.03e-05	0.00078	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NDUFB11—uterine cancer	4.74e-05	0.000735	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SRD5A2—uterine cancer	4.74e-05	0.000735	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—AKT1—uterine cancer	4.44e-05	0.000689	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CA—uterine cancer	3.79e-05	0.000588	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PTEN—uterine cancer	3.68e-05	0.000571	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—EP300—uterine cancer	3.51e-05	0.000545	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PTEN—uterine cancer	3.49e-05	0.000541	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—AKR1B1—uterine cancer	3.42e-05	0.000532	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—STAR—uterine cancer	3.42e-05	0.000532	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—EP300—uterine cancer	3.32e-05	0.000516	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—AKT1—uterine cancer	3.09e-05	0.00048	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PTEN—uterine cancer	3.06e-05	0.000475	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—EP300—uterine cancer	2.92e-05	0.000453	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—POLD1—uterine cancer	2.69e-05	0.000417	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CA—uterine cancer	2.6e-05	0.000403	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.51e-05	0.00039	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CA—uterine cancer	2.46e-05	0.000382	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—RRM2—uterine cancer	2.24e-05	0.000348	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—DCN—uterine cancer	2.17e-05	0.000338	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CA—uterine cancer	2.16e-05	0.000335	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—AKT1—uterine cancer	2.12e-05	0.000329	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.05e-05	0.000318	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—AKT1—uterine cancer	2.01e-05	0.000312	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.93e-05	0.0003	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—AKT1—uterine cancer	1.76e-05	0.000274	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—STK11—uterine cancer	1.51e-05	0.000234	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.51e-05	0.000234	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—MTHFR—uterine cancer	1.13e-05	0.000176	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PTEN—uterine cancer	6.3e-06	9.78e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—EP300—uterine cancer	6.01e-06	9.33e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CA—uterine cancer	4.45e-06	6.9e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—AKT1—uterine cancer	3.63e-06	5.64e-05	CbGpPWpGaD
